Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...
Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.
John Avlon talks with Annabelle Gurwitch about surviving stage-4 lung cancer—and what her experience reveals about America’s broken health system.
Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.
Mouth cancer chemotherapy (chemo), targeted therapy, and immunotherapy are called systemic therapies. They travel through the bloodstream to treat mouth cancer cells anywhere in the body. Your care ...
A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
FDA grants priority review to T-DXd for high-risk HER2-positive early breast cancer with residual disease, after trial shows markedly better recurrence-free survival than T-DM1.
Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and ...